CMS-D001

N/A

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameCMS-D001
Drug Alias NameCMS-D001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase 2 inhibitors
TargetsTyrosine-protein kinase 2
Therapy Area/IndicationsPlaque psoriasisAutoimmune DiseasesPsoriasis +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesChina Medical System Holdings Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShenzhen Kangzhe Biotechnology Co LtdDermavon Holdings LtdHainan Kangzhe Beauty Technology Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsPlaque psoriasisAutoimmune DiseasesPsoriasis +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A